United States · FDA National Drug Code directory
Orphenadrine Citrate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0591-3222_76bd2057-e1ac-4529-9663-f6139218eeab
- Product NDC
- 0591-3222
- Form
- INJECTION
- Composition / generic term
- Orphenadrine Citrate
- Labeler
- Actavis Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100708
- Source listing expiry
- 20261231
Source-listed ingredients
- ORPHENADRINE CITRATE — 30 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 AMPULE in 1 CARTON (0591-3222-47) / 2 mL in 1 AMPULE (0591-3222-02) · 0591-3222-47
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →